Pre-order Enquiry
Request Free Sample
Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Insights, Forecast to 2028
SKU ID : QYR-20528642 | Publishing Date : 18-Mar-2022 | No. of pages : 116
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Insights, Forecast to 2028
1 Report Business Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Aloxi (Palonosetron)
1.2.3 Kytril (Granisetron)
1.2.4 Emend (Aprepitant)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Acute Nausea and Vomitting Treatment
1.3.3 Delayed Nausea and Vomitting Treatment
1.3.4 Anticipatory Nausea and Vomitting Treatment
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Perspective (2017-2028)
2.2 Chemotheraphy-induced Nausea and Vomitting Treatment Growth Trends by Region
2.2.1 Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Region (2017-2022)
2.2.3 Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Region (2023-2028)
2.3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Dynamics
2.3.1 Chemotheraphy-induced Nausea and Vomitting Treatment Industry Trends
2.3.2 Chemotheraphy-induced Nausea and Vomitting Treatment Market Drivers
2.3.3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Challenges
2.3.4 Chemotheraphy-induced Nausea and Vomitting Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Revenue
3.1.1 Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Revenue (2017-2022)
3.1.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue
3.4 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Concentration Ratio
3.4.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue in 2021
3.5 Chemotheraphy-induced Nausea and Vomitting Treatment Key Players Head office and Area Served
3.6 Key Players Chemotheraphy-induced Nausea and Vomitting Treatment Product Solution and Service
3.7 Date of Enter into Chemotheraphy-induced Nausea and Vomitting Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemotheraphy-induced Nausea and Vomitting Treatment Breakdown Data by Type
4.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Type (2017-2022)
4.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Type (2023-2028)
5 Chemotheraphy-induced Nausea and Vomitting Treatment Breakdown Data by Application
5.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Application (2017-2022)
5.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2017-2028)
6.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
6.2.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022)
6.2.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2023-2028)
6.2.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2017-2028)
6.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
6.3.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022)
6.3.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2023-2028)
6.3.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2017-2028)
6.4 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country
6.4.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022)
6.4.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2017-2028)
7.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
7.2.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022)
7.2.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2023-2028)
7.2.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2017-2028)
7.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
7.3.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022)
7.3.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2023-2028)
7.3.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2017-2028)
7.4 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country
7.4.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022)
7.4.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2017-2028)
8.2 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
8.2.1 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
8.3.1 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region
8.4.1 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2017-2028)
9.2 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
9.2.1 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2017-2028)
9.3 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
9.3.1 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2017-2028)
9.4 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country
9.4.1 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2017-2028)
10.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
10.2.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
10.3.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country
10.4.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Helsinn
11.2.1 Helsinn Company Details
11.2.2 Helsinn Business Overview
11.2.3 Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.2.4 Helsinn Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.2.5 Helsinn Recent Developments
11.3 Heron Therapeutics
11.3.1 Heron Therapeutics Company Details
11.3.2 Heron Therapeutics Business Overview
11.3.3 Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.3.4 Heron Therapeutics Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.3.5 Heron Therapeutics Recent Developments
11.4 Merck & Co
11.4.1 Merck & Co Company Details
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.4.4 Merck & Co Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.4.5 Merck & Co Recent Developments
11.5 Tesaro
11.5.1 Tesaro Company Details
11.5.2 Tesaro Business Overview
11.5.3 Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.5.4 Tesaro Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.5.5 Tesaro Recent Developments
11.6 Acacia Pharma
11.6.1 Acacia Pharma Company Details
11.6.2 Acacia Pharma Business Overview
11.6.3 Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.6.4 Acacia Pharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.6.5 Acacia Pharma Recent Developments
11.7 Aphios
11.7.1 Aphios Company Details
11.7.2 Aphios Business Overview
11.7.3 Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.7.4 Aphios Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.7.5 Aphios Recent Developments
11.8 Barr Laboratories
11.8.1 Barr Laboratories Company Details
11.8.2 Barr Laboratories Business Overview
11.8.3 Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.8.4 Barr Laboratories Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.8.5 Barr Laboratories Recent Developments
11.9 Baxter Healthcare
11.9.1 Baxter Healthcare Company Details
11.9.2 Baxter Healthcare Business Overview
11.9.3 Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.9.4 Baxter Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.9.5 Baxter Healthcare Recent Developments
11.10 Eisai
11.10.1 Eisai Company Details
11.10.2 Eisai Business Overview
11.10.3 Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.10.4 Eisai Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.10.5 Eisai Recent Developments
11.11 Especificos Stendhal
11.11.1 Especificos Stendhal Company Details
11.11.2 Especificos Stendhal Business Overview
11.11.3 Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.11.4 Especificos Stendhal Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.11.5 Especificos Stendhal Recent Developments
11.12 F.Hoffmann La Roche
11.12.1 F.Hoffmann La Roche Company Details
11.12.2 F.Hoffmann La Roche Business Overview
11.12.3 F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.12.4 F.Hoffmann La Roche Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.12.5 F.Hoffmann La Roche Recent Developments
11.13 Mundipharma
11.13.1 Mundipharma Company Details
11.13.2 Mundipharma Business Overview
11.13.3 Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.13.4 Mundipharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.13.5 Mundipharma Recent Developments
11.14 Mylan Pharmaceuticals
11.14.1 Mylan Pharmaceuticals Company Details
11.14.2 Mylan Pharmaceuticals Business Overview
11.14.3 Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.14.4 Mylan Pharmaceuticals Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.14.5 Mylan Pharmaceuticals Recent Developments
11.15 OPKO Health
11.15.1 OPKO Health Company Details
11.15.2 OPKO Health Business Overview
11.15.3 OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.15.4 OPKO Health Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.15.5 OPKO Health Recent Developments
11.16 Orchid Healthcare
11.16.1 Orchid Healthcare Company Details
11.16.2 Orchid Healthcare Business Overview
11.16.3 Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.16.4 Orchid Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
11.16.5 Orchid Healthcare Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Figures, Tables and Charts Available in Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Insights, Forecast to 2028
List of TablesTable 1. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Aloxi (Palonosetron)
Table 3. Key Players of Kytril (Granisetron)
Table 4. Key Players of Emend (Aprepitant)
Table 5. Key Players of Others
Table 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2017-2022)
Table 10. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2023-2028)
Table 12. Chemotheraphy-induced Nausea and Vomitting Treatment Market Trends
Table 13. Chemotheraphy-induced Nausea and Vomitting Treatment Market Drivers
Table 14. Chemotheraphy-induced Nausea and Vomitting Treatment Market Challenges
Table 15. Chemotheraphy-induced Nausea and Vomitting Treatment Market Restraints
Table 16. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2021)
Table 19. Ranking of Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chemotheraphy-induced Nausea and Vomitting Treatment Product Solution and Service
Table 23. Date of Enter into Chemotheraphy-induced Nausea and Vomitting Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Share by Application (2017-2022)
Table 31. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Share by Application (2023-2028)
Table 33. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. GlaxoSmithKline Company Details
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 66. GlaxoSmithKline Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 67. GlaxoSmithKline Recent Developments
Table 68. Helsinn Company Details
Table 69. Helsinn Business Overview
Table 70. Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 71. Helsinn Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 72. Helsinn Recent Developments
Table 73. Heron Therapeutics Company Details
Table 74. Heron Therapeutics Business Overview
Table 75. Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 76. Heron Therapeutics Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 77. Heron Therapeutics Recent Developments
Table 78. Merck & Co Company Details
Table 79. Merck & Co Business Overview
Table 80. Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 81. Merck & Co Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 82. Merck & Co Recent Developments
Table 83. Tesaro Company Details
Table 84. Tesaro Business Overview
Table 85. Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 86. Tesaro Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 87. Tesaro Recent Developments
Table 88. Acacia Pharma Company Details
Table 89. Acacia Pharma Business Overview
Table 90. Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 91. Acacia Pharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 92. Acacia Pharma Recent Developments
Table 93. Aphios Company Details
Table 94. Aphios Business Overview
Table 95. Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 96. Aphios Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 97. Aphios Recent Developments
Table 98. Barr Laboratories Company Details
Table 99. Barr Laboratories Business Overview
Table 100. Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 101. Barr Laboratories Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 102. Barr Laboratories Recent Developments
Table 103. Baxter Healthcare Company Details
Table 104. Baxter Healthcare Business Overview
Table 105. Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 106. Baxter Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 107. Baxter Healthcare Recent Developments
Table 108. Eisai Company Details
Table 109. Eisai Business Overview
Table 110. Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 111. Eisai Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 112. Eisai Recent Developments
Table 113. Especificos Stendhal Company Details
Table 114. Especificos Stendhal Business Overview
Table 115. Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 116. Especificos Stendhal Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 117. Especificos Stendhal Recent Developments
Table 118. F.Hoffmann La Roche Company Details
Table 119. F.Hoffmann La Roche Business Overview
Table 120. F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 121. F.Hoffmann La Roche Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 122. F.Hoffmann La Roche Recent Developments
Table 123. Mundipharma Company Details
Table 124. Mundipharma Business Overview
Table 125. Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 126. Mundipharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 127. Mundipharma Recent Developments
Table 128. Mylan Pharmaceuticals Company Details
Table 129. Mylan Pharmaceuticals Business Overview
Table 130. Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 131. Mylan Pharmaceuticals Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 132. Mylan Pharmaceuticals Recent Developments
Table 133. OPKO Health Company Details
Table 134. OPKO Health Business Overview
Table 135. OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 136. OPKO Health Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 137. OPKO Health Recent Developments
Table 138. Orchid Healthcare Company Details
Table 139. Orchid Healthcare Business Overview
Table 140. Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 141. Orchid Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 142. Orchid Healthcare Recent Developments
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type: 2021 VS 2028
Figure 2. Aloxi (Palonosetron) Features
Figure 3. Kytril (Granisetron) Features
Figure 4. Emend (Aprepitant) Features
Figure 5. Others Features
Figure 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application: 2021 VS 2028
Figure 7. Acute Nausea and Vomitting Treatment Case Studies
Figure 8. Delayed Nausea and Vomitting Treatment Case Studies
Figure 9. Anticipatory Nausea and Vomitting Treatment Case Studies
Figure 10. Chemotheraphy-induced Nausea and Vomitting Treatment Report Years Considered
Figure 11. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Players in 2021
Figure 15. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue in 2021
Figure 17. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type (2017-2028)
Figure 19. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application (2017-2028)
Figure 20. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Share by Country (2017-2028)
Figure 21. United States Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type (2017-2028)
Figure 25. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application (2017-2028)
Figure 26. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Share by Country (2017-2028)
Figure 27. Germany Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Share by Region (2017-2028)
Figure 37. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Share by Country (2017-2028)
Figure 47. Mexico Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Share by Country (2017-2028)
Figure 53. Turkey Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 57. Helsinn Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 58. Heron Therapeutics Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 59. Merck & Co Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 60. Tesaro Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 61. Acacia Pharma Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 62. Aphios Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 63. Barr Laboratories Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 64. Baxter Healthcare Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 65. Eisai Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 66. Especificos Stendhal Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 67. F.Hoffmann La Roche Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 68. Mundipharma Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 69. Mylan Pharmaceuticals Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 70. OPKO Health Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 71. Orchid Healthcare Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Keyplayers in Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Insights, Forecast to 2028
GlaxoSmithKlineHelsinn
Heron Therapeutics
Merck & Co
Tesaro
Acacia Pharma
Aphios
Barr Laboratories
Baxter Healthcare
Eisai
Especificos Stendhal
F.Hoffmann La Roche
Mundipharma
Mylan Pharmaceuticals
OPKO Health
Orchid Healthcare
